Home
PFE
PFE News

Latest Pfizer Inc. (PFE) News on July 1, 2025

Pfizer (NYSE:PFE) Expands Collaboration With XtalPi To Enhance Drug Discovery Platform

Simply Wall St.

a day ago

Pfizer (NYSE:PFE) Expands Collaboration With XtalPi To Enhance Drug Discovery Platform

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

Zacks

a day ago

BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

PR Newswire

2 days ago

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

3 No-Brainer Stocks to Buy for Under $100 Right Now

Motley Fool

3 days ago

3 No-Brainer Stocks to Buy for Under $100 Right Now

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

Insider Monkey

3 days ago

Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment

PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

Zacks

4 days ago

PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

Pfizer reports positive results from Phase III BASIS trial for haemophilia

Clinical Trials Arena

4 days ago

Pfizer reports positive results from Phase III BASIS trial for haemophilia

Sickle Cell Disease Treatment Market Analysis and Forecast, 2025-2035 | Intensifying Competition as Key Players Advance Gene and Novel Therapies

GlobeNewswire

4 days ago

Sickle Cell Disease Treatment Market Analysis and Forecast, 2025-2035 | Intensifying Competition as Key Players Advance Gene and Novel Therapies

Smartly’s Flagship Event ADVANCE Returns: New Voices, Big Ideas, and the Future of Marketing

Business Wire

5 days ago

Smartly’s Flagship Event ADVANCE Returns: New Voices, Big Ideas, and the Future of Marketing

Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025

Pharmaceutical Technology

5 days ago

Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025

MT Newswires

5 days ago

Pfizer's Hympavzi Meets Primary Endpoint in Phase 3 Trial for Hemophilia A, B Treatment

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

Business Wire

5 days ago

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

Pfizer Declares Third-Quarter 2025 Dividend

Business Wire

6 days ago

Pfizer Declares Third-Quarter 2025 Dividend

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Zacks

6 days ago

Will New Drugs Enable BMY to Offset the Impact of Generic Competition?

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

Business Wire

6 days ago

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

GlobeNewswire

6 days ago

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

Does Pfizer (NYSE:PFE) Have A Healthy Balance Sheet?

Simply Wall St.

6 days ago

Does Pfizer (NYSE:PFE) Have A Healthy Balance Sheet?

3 Reasons PFE is Risky and 1 Stock to Buy Instead

StockStory

7 days ago

3 Reasons PFE is Risky and 1 Stock to Buy Instead

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

7 days ago

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Zacks

7 days ago

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?

Zacks

7 days ago

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Motley Fool

7 days ago

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Kinase Inhibitors in Autoimmune Diseases Research Report 2025-2035 | Market Accelerates Amid Rising Disease Prevalence, Kinase Innovation, and Demand for Safer Treatments

GlobeNewswire

7 days ago

Kinase Inhibitors in Autoimmune Diseases Research Report 2025-2035 | Market Accelerates Amid Rising Disease Prevalence, Kinase Innovation, and Demand for Safer Treatments

Pfizer’s Dividend Backed by Strong Free Cash Flow

Insider Monkey

8 days ago

Pfizer’s Dividend Backed by Strong Free Cash Flow

Ireland Warns Thousands of Jobs at Risk From Pharma Tariffs

Bloomberg

8 days ago

Ireland Warns Thousands of Jobs at Risk From Pharma Tariffs

The 5 Most Interesting Analyst Questions From Pfizer’s Q1 Earnings Call

StockStory

9 days ago

The 5 Most Interesting Analyst Questions From Pfizer’s Q1 Earnings Call

Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment

Simply Wall St.

11 days ago

Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment

Pfizer (NYSE:PFE) Joins FIBRE Consortium To Advance Fibrosis Treatment Through Innovative Imaging

Simply Wall St.

11 days ago

Pfizer (NYSE:PFE) Joins FIBRE Consortium To Advance Fibrosis Treatment Through Innovative Imaging

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.

Barrons.com

11 days ago

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

Zacks

11 days ago

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

Zacks

11 days ago

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

The past three years for Pfizer (NYSE:PFE) investors has not been profitable

Simply Wall St.

12 days ago

The past three years for Pfizer (NYSE:PFE) investors has not been profitable

Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

Zacks

12 days ago

Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.

Barrons.com

12 days ago

Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.

Trump administration weighs crackdown on pharma ads, Bloomberg says

TipRanks

13 days ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

2 Top Stocks to Buy With Less Than $30

Motley Fool

13 days ago

2 Top Stocks to Buy With Less Than $30

Trump's big beautiful bill: What the pharma industry is watching

Yahoo Finance Video

14 days ago

Trump's big beautiful bill: What the pharma industry is watching

AMD extends gains, solar stocks plummet, pharma stocks

Yahoo Finance Video

14 days ago

AMD extends gains, solar stocks plummet, pharma stocks

Trump reportedly threatens pharma ads, disrupting $10B market

Yahoo Finance Video

14 days ago

Trump reportedly threatens pharma ads, disrupting $10B market

RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market

Bloomberg

14 days ago

RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market

MT Newswires

14 days ago

Market Chatter: Trump Administration to Consider Pharma Advertising Crackdown

Should Value Investors Buy Pfizer (PFE) Stock?

Zacks

14 days ago

Should Value Investors Buy Pfizer (PFE) Stock?

5 Low Price-to-Book Value Stocks That You Can Buy in June

Zacks

14 days ago

5 Low Price-to-Book Value Stocks That You Can Buy in June

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock

Motley Fool

14 days ago

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock

PFE or LLY: Which Is the Better Value Stock Right Now?

Zacks

15 days ago

PFE or LLY: Which Is the Better Value Stock Right Now?

EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy

Zacks

15 days ago

EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy

4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil

Zacks

15 days ago

4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

Zacks

15 days ago

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

Zacks

15 days ago

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of

StockStory

16 days ago

1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of

Pfizer Inc. (NYSE:PFE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Simply Wall St.

16 days ago

Pfizer Inc. (NYSE:PFE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Senators to propose ban on drug ads to consumers, WSJ reports

TipRanks

18 days ago

Senators to propose ban on drug ads to consumers, WSJ reports

JPMorgan biotech/pharma analysts hold analyst/industry conference call

TipRanks

18 days ago

JPMorgan biotech/pharma analysts hold analyst/industry conference call

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?

Zacks

18 days ago

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?

PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds

Zacks

19 days ago

PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds

Novavax's COVID-Flu Combo Shot Shows Strong Immune Response

Zacks

19 days ago

Novavax's COVID-Flu Combo Shot Shows Strong Immune Response

Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%

Motley Fool

19 days ago

Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%

Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)

Insider Monkey

20 days ago

Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

TipRanks

20 days ago

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Pfizer says drugmakers met with Trump admin to discuss lowering drug prices

TipRanks

20 days ago

Pfizer says drugmakers met with Trump admin to discuss lowering drug prices

Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee

Investor's Business Daily

21 days ago

Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

Zacks

21 days ago

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.

Barrons.com

21 days ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.

Top Cancer Stocks to Supercharge Your 2025 Portfolio

Zacks

21 days ago

Top Cancer Stocks to Supercharge Your 2025 Portfolio

BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom

Bloomberg

21 days ago

BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom

RFK Jr. removes CDC vaccine panel members: What to know

Yahoo Finance Video

21 days ago

RFK Jr. removes CDC vaccine panel members: What to know

RFK Jr. Fires All 17 Members of CDC’s Vaccine Advisory Board

Barrons.com

22 days ago

RFK Jr. Fires All 17 Members of CDC’s Vaccine Advisory Board

Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.

Investor's Business Daily

22 days ago

Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.

MT Newswires

22 days ago

Pfizer CEO Says No Deals Yet in US Drug Price Talks

Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?

Zacks

22 days ago

Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Zacks

22 days ago

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says

Reuters

22 days ago

No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Motley Fool

23 days ago

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Failed Muni Bond Draws FBI and Sparks ‘Ponzi-Like Fraud’ Claims

Bloomberg

24 days ago

Failed Muni Bond Draws FBI and Sparks ‘Ponzi-Like Fraud’ Claims

Should You Buy Pfizer Stock Right Now?

Motley Fool

24 days ago

Should You Buy Pfizer Stock Right Now?

Patents and economies of scale support Pfizer's wide moat

GuruFocus.com

24 days ago

Patents and economies of scale support Pfizer's wide moat

2 Beaten-Down Dividend Stocks to Buy Now and Hold at Least a Decade

Motley Fool

24 days ago

2 Beaten-Down Dividend Stocks to Buy Now and Hold at Least a Decade

Challenges pharma companies face in push into US manufacturing

Yahoo Finance Video

25 days ago

Challenges pharma companies face in push into US manufacturing

Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?

Insider Monkey

25 days ago

Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?

Was Jim Cramer Right About Pfizer Inc. (PFE)?

Insider Monkey

25 days ago

Was Jim Cramer Right About Pfizer Inc. (PFE)?

BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?

Zacks

25 days ago

BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?

MT Newswires

25 days ago

Arvinas, Pfizer Submit New Drug Application for Vepdegestrant as Breast Cancer Treatment

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

GlobeNewswire

25 days ago

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Zacks.com featured highlights JAKKS Pacific, Green Dot, Signet Jewelers, Gibraltar Industries and Pfizer

Zacks

25 days ago

Zacks.com featured highlights JAKKS Pacific, Green Dot, Signet Jewelers, Gibraltar Industries and Pfizer

Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China

Simply Wall St.

a month ago

Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China

5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential

Zacks

a month ago

5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential

Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot

The Wall Street Journal

a month ago

Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Motley Fool

a month ago

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Here Are All 6 Stocks I've Bought Through 5 Months of 2025

Motley Fool

a month ago

Here Are All 6 Stocks I've Bought Through 5 Months of 2025

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

Zacks

a month ago

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

EC approves Takeda ADC plus chemo for stage IIb Hodgkin’s lymphoma

Pharmaceutical Technology

a month ago

EC approves Takeda ADC plus chemo for stage IIb Hodgkin’s lymphoma

3 Healthcare Stocks in Hot Water

StockStory

a month ago

3 Healthcare Stocks in Hot Water

Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike

Zacks

a month ago

Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike

Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook

Zacks

a month ago

Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook

How Moderna Went From Pandemic Hero to Vaccine Victim

The Wall Street Journal

a month ago

How Moderna Went From Pandemic Hero to Vaccine Victim

3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June

Motley Fool

a month ago

3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June

Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech

Barrons.com

a month ago

Bristol Myers Joins Pharma’s Hottest Horserace in $11.1B Deal With BioNTech

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire

a month ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Bloomberg

a month ago

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

MT Newswires

a month ago

Arvinas, Pfizer Report Breast Cancer Treatment Phase 3 Trial Results; Arvinas Shares Down Pre-Bell

Share on Social Networks: